China Traditional Chinese Medicine Holdings Co. Limited (CHIZF)
- Previous Close
0.4773 - Open
0.4773 - Bid --
- Ask --
- Day's Range
0.4773 - 0.4773 - 52 Week Range
0.4773 - 0.4773 - Volume
560 - Avg. Volume
0 - Market Cap (intraday)
2.404B - Beta (5Y Monthly) 0.52
- PE Ratio (TTM)
23.86 - EPS (TTM)
0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 2, 2023
- 1y Target Est
--
China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of Chinese medicine and pharmaceutical products in the People's Republic of China. The company manufactures and sells concentrated TCM granules, health care products, and decoction pieces under the Yi Fang, Tian Jiang, and Tong Ji Tang brand names; and offers Chinese medical related healthcare solutions including Chinese medical consultation and diagnosis through offline medical institutions. It also provides manufacture and sale of TCM finished drugs under various brands, such as Medi-world, De Zhong, and Feng Liao Xing brands. In addition, the company engages in sale of medical herbs; TCM markets, advertises, and consulting; and property leasing services. It sells its products to hospitals and retail pharmacies. The company was formerly known as China Traditional Chinese Medicine Co. Limited and changed its name to China Traditional Chinese Medicine Holdings Co. Limited in 2016. China Traditional China Traditional Chinese Medicine Holdings Co. Limited was founded in 1573 and is based in Wan Chai, Hong Kong.
www.china-tcm.com.cn17,303
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: CHIZF
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHIZF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHIZF
Valuation Measures
Market Cap
2.78B
Enterprise Value
2.96B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
0.16
Enterprise Value/EBITDA
2.08
Financial Highlights
Profitability and Income Statement
Profit Margin
7.09%
Return on Assets (ttm)
2.32%
Return on Equity (ttm)
5.96%
Revenue (ttm)
18.12B
Net Income Avi to Common (ttm)
1.29B
Diluted EPS (ttm)
0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
3.9B
Total Debt/Equity (mrq)
21.56%
Levered Free Cash Flow (ttm)
--
Company Insights: CHIZF
CHIZF does not have Company Insights